Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$37.91
+0.7%
$33.05
$25.24
$43.11
$1.88B1.61582,086 shs198,737 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$14.28
-3.9%
$12.77
$11.06
$27.13
$1.11B1.161.03 million shs788,496 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$14.51
-0.3%
$11.74
$10.24
$20.73
$572.80M0.82328,562 shs180,044 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$35.33
-5.0%
$32.86
$26.00
$40.38
$505.23M1.31193,941 shs123,507 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
0.00%+6.23%+19.56%+15.13%+48.03%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
0.00%+4.72%+13.35%+20.81%-29.47%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.00%+2.25%+29.10%+31.08%-15.85%
Surmodics, Inc. stock logo
SRDX
Surmodics
0.00%-0.72%+3.31%+29.58%-6.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AtriCure, Inc. stock logo
ATRC
AtriCure
2.9863 of 5 stars
3.52.00.00.03.42.50.6
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4.273 of 5 stars
2.91.00.04.03.11.72.5
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.9337 of 5 stars
3.52.00.00.03.22.50.6
Surmodics, Inc. stock logo
SRDX
Surmodics
3.9815 of 5 stars
2.13.00.03.43.51.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
3.00
Buy$50.8934.23% Upside
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.78
Reduce$18.6330.43% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
3.00
Buy$21.5048.22% Upside
Surmodics, Inc. stock logo
SRDX
Surmodics
2.25
Hold$43.0021.71% Upside

Current Analyst Ratings Breakdown

Latest SRDX, ATRC, IART, and OFIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
8/11/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
7/30/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$54.00
7/30/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$44.00 ➝ $45.00
6/23/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$16.00
6/6/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
(Data available from 8/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$465.31M4.05N/AN/A$9.46 per share4.01
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$1.61B0.69$4.28 per share3.34$20.03 per share0.71
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$799.49M0.72N/AN/A$13.07 per share1.11
Surmodics, Inc. stock logo
SRDX
Surmodics
$126.08M4.01$0.29 per share120.21$8.33 per share4.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$44.70M-$0.77N/AN/AN/A-7.27%-4.20%-3.19%11/4/2025 (Estimated)
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-$6.94M-$6.53N/A5.710.84-30.87%12.15%4.32%11/3/2025 (Estimated)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$126M-$3.17N/AN/AN/A-15.29%-25.43%-14.46%11/6/2025 (Estimated)
Surmodics, Inc. stock logo
SRDX
Surmodics
-$11.54M-$1.23N/A44.16N/A-14.59%-2.99%-1.99%11/5/2025 (Estimated)

Latest SRDX, ATRC, IART, and OFIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q3 2025
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.21$0.06+$0.27-$0.37$28.04 million$29.57 million
8/5/2025Q2 2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$0.04-$0.36-$0.40-$0.36$196.89 million$203.12 million
7/31/2025Q2 2025
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.43$0.45+$0.02-$6.31$395.06 million$415.61 million
7/29/2025Q2 2025
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.15-$0.02+$0.13-$0.13$130.17 million$136.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
Surmodics, Inc. stock logo
SRDX
Surmodics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.16
3.94
2.83
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.18
1.23
0.73
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.38
2.67
1.50
Surmodics, Inc. stock logo
SRDX
Surmodics
0.27
3.91
3.10

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
84.78%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%
Surmodics, Inc. stock logo
SRDX
Surmodics
96.63%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
3.50%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3.54%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1.30%
Surmodics, Inc. stock logo
SRDX
Surmodics
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,30049.70 million47.96 millionOptionable
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4,39677.91 million75.15 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,61639.49 million38.98 millionOptionable
Surmodics, Inc. stock logo
SRDX
Surmodics
45014.30 million13.03 millionOptionable

Recent News About These Companies

Barrington Research Forecasts Surmodics FY2025 Earnings
What's Next: Surmodics's Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$37.91 +0.25 (+0.67%)
Closing price 03:59 PM Eastern
Extended Trading
$37.85 -0.06 (-0.16%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$14.28 -0.58 (-3.90%)
Closing price 03:59 PM Eastern
Extended Trading
$14.27 -0.01 (-0.07%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Orthofix Medical stock logo

Orthofix Medical NASDAQ:OFIX

$14.50 -0.05 (-0.31%)
Closing price 03:59 PM Eastern
Extended Trading
$14.50 -0.01 (-0.07%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Surmodics stock logo

Surmodics NASDAQ:SRDX

$35.33 -1.86 (-5.00%)
Closing price 03:59 PM Eastern
Extended Trading
$35.31 -0.02 (-0.06%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.